Compare $KRMD vs $STXS | Chartloom

Compare

$KRMD vs $STXS

KORU Medical Systems Inc · Stereotaxis Inc

KRMD

KORU Medical Systems Inc

STXS

Stereotaxis Inc

Compare $KRMD vs $STXS

Comparing KORU Medical Systems Inc and Stereotaxis Inc

KRMDKORU Medical Systems Inc

STXSStereotaxis Inc

KRMDKORU Medical Systems Inc

Market cap

$136M

P/E (TTM)

—

Forward P/E (NTM)

1,748.17x

Forward P/S (NTM)

2.55x

Rev growth (TTM)

22.4%

YTD performance

-47.2%

52W performance

-29.4%

FCF yield

0.2%

STXSStereotaxis Inc

Market cap

$111M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.57x

Rev growth (TTM)

-5.5%

YTD performance

-52.2%

52W performance

-68.9%

FCF yield

-14.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KRMD

STXS

Detailed metrics comparison

KRMD

KORU Medical Systems Inc

STXS

Stereotaxis Inc

Market Cap

KRMD$136M

STXS$111M

Enterprise Value

KRMD$128M

STXS$100M

Price

KRMD$2.96

STXS$1.11

P/E Ratio

KRMDN/A

STXSN/A

P/S Ratio

KRMD3.01x

STXS3.68x

EV/Sales

KRMD2.84x

STXS3.33x

EV/EBITDA

KRMD918.58x

STXS234.23x

P/B Ratio

KRMD7.57x

STXS6.77x

P/FCF Ratio

KRMD559.48x

STXSN/A

EV/FCF

KRMD526.28x

STXS-6.46x

PEG Ratio

KRMDN/A

STXSN/A

Forward P/E (NTM)

KRMD1,748.17x

STXSN/A

Forward P/S (NTM)

KRMD2.55x

STXS2.57x

Revenue (TTM)

KRMD$45M

STXS$30M

Revenue Growth (YoY)

KRMD22.4%

STXS-5.5%

Forward Rev Growth

KRMD17.2%

STXS33.0%

Gross Margin (TTM)

KRMD62.4%

STXS55.6%

Operating Margin (TTM)

KRMD0.0%

STXS0.0%

EBITDA Margin (TTM)

KRMD-1.9%

STXS-60.1%

Net Margin (TTM)

KRMD-4.0%

STXS-78.5%

FCF Margin (TTM)

KRMD0.5%

STXS-51.6%

Net Income (TTM)

KRMD$-2M

STXS$-24M

FCF (TTM)

KRMD$243K

STXS$-16M

EPS (TTM)

KRMD-$0.04

STXS-$0.24

ROE (TTM)

KRMD-1063.0%

STXS-13262.0%

ROA (TTM)

KRMD-651.0%

STXS-4304.0%

ROIC (TTM)

KRMD-1045.0%

STXS-13262.0%

Cash

KRMD$8M

STXS$10M

Debt

KRMD$220K

STXS$0

Net Cash/Debt

KRMD$8M

STXS$10M

Current Ratio (TTM)

KRMD2.72x

STXS1.42x

Quick Ratio (TTM)

KRMD2.00x

STXS0.91x

Debt/Equity (TTM)

KRMD0.01x

STXS0.00x

Debt/Assets (TTM)

KRMD0.0%

STXS0.0%

Interest Coverage (TTM)

KRMDN/A

STXSN/A

Net Debt/EBITDA (TTM)

KRMD0.00x

STXS0.00x

Beta

KRMD0.52

STXS1.40

52W Performance

KRMD-29.4%

STXS-68.9%

YTD Performance

KRMD-47.2%

STXS-52.2%

% from 52W High

KRMD-55.2%

STXS-69.1%

% from 52W Low

KRMD3.5%

STXS1.8%

Asset Turnover (TTM)

KRMD1.61x

STXS0.58x

FCF Yield (TTM)

KRMD0.2%

STXS-14.0%

Earnings Yield (TTM)

KRMD-1.3%

STXS-21.3%

Dividend Yield (TTM)

KRMDN/A

STXSN/A

Rule of 40

KRMD23.0

STXS-57.0

EV/GP/RG

KRMD0.25

STXS0.14

Ticker research

View KRMD research View STXS research

Metric	KRMD KORU Medical Systems Inc	STXS Stereotaxis Inc
Market & Valuation
Market Cap	$136M	$111M
Enterprise Value	$128M	$100M
Price	$2.96	$1.11
P/E Ratio	N/A	N/A
P/S Ratio	3.01x	3.68x
EV/Sales	2.84x	3.33x
EV/EBITDA	918.58x	234.23x
P/B Ratio	7.57x	6.77x
P/FCF Ratio	559.48x	N/A
EV/FCF	526.28x	-6.46x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1,748.17x	N/A
Forward P/S (NTM)	2.55x	2.57x
Revenue & Growth
Revenue (TTM)	$45M	$30M
Revenue Growth (YoY)	22.4%	-5.5%
Forward Rev Growth	17.2%	33.0%
Profitability
Gross Margin (TTM)	62.4%	55.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-60.1%
Net Margin (TTM)	-4.0%	-78.5%
FCF Margin (TTM)	0.5%	-51.6%
Net Income (TTM)	$-2M	$-24M
FCF (TTM)	$243K	$-16M
EPS (TTM)	-$0.04	-$0.24
ROE (TTM)	-1063.0%	-13262.0%
ROA (TTM)	-651.0%	-4304.0%
ROIC (TTM)	-1045.0%	-13262.0%
Financial Health
Cash	$8M	$10M
Debt	$220K	$0
Net Cash/Debt	$8M	$10M
Current Ratio (TTM)	2.72x	1.42x
Quick Ratio (TTM)	2.00x	0.91x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	1.40
52W Performance	-29.4%	-68.9%
YTD Performance	-47.2%	-52.2%
% from 52W High	-55.2%	-69.1%
% from 52W Low	3.5%	1.8%
Efficiency & Yields
Asset Turnover (TTM)	1.61x	0.58x
FCF Yield (TTM)	0.2%	-14.0%
Earnings Yield (TTM)	-1.3%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	23.0	-57.0
EV/GP/RG	0.25	0.14
Ticker research	View KRMD research	View STXS research

Valuation

P/S Ratio

KRMD

3.01x

STXS

3.68x

EV/FCF

STXS

-6.46x

KRMD

526.28x

Growth & revenue

Revenue Growth TTM

KRMD

22.4%

STXS

-5.5%

Forward Revenue Growth

STXS

33.0%

KRMD

17.2%

Profitability & performance

Gross Margin

KRMD

62.4%

STXS

55.6%

ROE

KRMD

-1063.0%

STXS

-13262.0%

FCF Yield %

KRMD

0.2%

STXS

-14.0%

52-Week Performance

KRMD

-29.4%

STXS

-68.9%

Detailed metrics comparison

KRMD

KORU Medical Systems Inc

STXS

Stereotaxis Inc

Market Cap

KRMD$136M

STXS$111M

Enterprise Value

KRMD$128M

STXS$100M

Price

KRMD$2.96

STXS$1.11

P/E Ratio

KRMDN/A

STXSN/A

P/S Ratio

KRMD3.01x

STXS3.68x

EV/Sales

KRMD2.84x

STXS3.33x

EV/EBITDA

KRMD918.58x

STXS234.23x

P/B Ratio

KRMD7.57x

STXS6.77x

P/FCF Ratio

KRMD559.48x

STXSN/A

EV/FCF

KRMD526.28x

STXS-6.46x

PEG Ratio

KRMDN/A

STXSN/A

Forward P/E (NTM)

KRMD1,748.17x

STXSN/A

Forward P/S (NTM)

KRMD2.55x

STXS2.57x

Revenue (TTM)

KRMD$45M

STXS$30M

Revenue Growth (YoY)

KRMD22.4%

STXS-5.5%

Forward Rev Growth

KRMD17.2%

STXS33.0%

Gross Margin (TTM)

KRMD62.4%

STXS55.6%

Operating Margin (TTM)

KRMD0.0%

STXS0.0%

EBITDA Margin (TTM)

KRMD-1.9%

STXS-60.1%

Net Margin (TTM)

KRMD-4.0%

STXS-78.5%

FCF Margin (TTM)

KRMD0.5%

STXS-51.6%

Net Income (TTM)

KRMD$-2M

STXS$-24M

FCF (TTM)

KRMD$243K

STXS$-16M

EPS (TTM)

KRMD-$0.04

STXS-$0.24

ROE (TTM)

KRMD-1063.0%

STXS-13262.0%

ROA (TTM)

KRMD-651.0%

STXS-4304.0%

ROIC (TTM)

KRMD-1045.0%

STXS-13262.0%

Cash

KRMD$8M

STXS$10M

Debt

KRMD$220K

STXS$0

Net Cash/Debt

KRMD$8M

STXS$10M

Current Ratio (TTM)

KRMD2.72x

STXS1.42x

Quick Ratio (TTM)

KRMD2.00x

STXS0.91x

Debt/Equity (TTM)

KRMD0.01x

STXS0.00x

Debt/Assets (TTM)

KRMD0.0%

STXS0.0%

Interest Coverage (TTM)

KRMDN/A

STXSN/A

Net Debt/EBITDA (TTM)

KRMD0.00x

STXS0.00x

Beta

KRMD0.52

STXS1.40

52W Performance

KRMD-29.4%

STXS-68.9%

YTD Performance

KRMD-47.2%

STXS-52.2%

% from 52W High

KRMD-55.2%

STXS-69.1%

% from 52W Low

KRMD3.5%

STXS1.8%

Asset Turnover (TTM)

KRMD1.61x

STXS0.58x

FCF Yield (TTM)

KRMD0.2%

STXS-14.0%

Earnings Yield (TTM)

KRMD-1.3%

STXS-21.3%

Dividend Yield (TTM)

KRMDN/A

STXSN/A

Rule of 40

KRMD23.0

STXS-57.0

EV/GP/RG

KRMD0.25

STXS0.14

Ticker research

View KRMD research View STXS research

Metric	KRMD KORU Medical Systems Inc	STXS Stereotaxis Inc
Market & Valuation
Market Cap	$136M	$111M
Enterprise Value	$128M	$100M
Price	$2.96	$1.11
P/E Ratio	N/A	N/A
P/S Ratio	3.01x	3.68x
EV/Sales	2.84x	3.33x
EV/EBITDA	918.58x	234.23x
P/B Ratio	7.57x	6.77x
P/FCF Ratio	559.48x	N/A
EV/FCF	526.28x	-6.46x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1,748.17x	N/A
Forward P/S (NTM)	2.55x	2.57x
Revenue & Growth
Revenue (TTM)	$45M	$30M
Revenue Growth (YoY)	22.4%	-5.5%
Forward Rev Growth	17.2%	33.0%
Profitability
Gross Margin (TTM)	62.4%	55.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-60.1%
Net Margin (TTM)	-4.0%	-78.5%
FCF Margin (TTM)	0.5%	-51.6%
Net Income (TTM)	$-2M	$-24M
FCF (TTM)	$243K	$-16M
EPS (TTM)	-$0.04	-$0.24
ROE (TTM)	-1063.0%	-13262.0%
ROA (TTM)	-651.0%	-4304.0%
ROIC (TTM)	-1045.0%	-13262.0%
Financial Health
Cash	$8M	$10M
Debt	$220K	$0
Net Cash/Debt	$8M	$10M
Current Ratio (TTM)	2.72x	1.42x
Quick Ratio (TTM)	2.00x	0.91x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	1.40
52W Performance	-29.4%	-68.9%
YTD Performance	-47.2%	-52.2%
% from 52W High	-55.2%	-69.1%
% from 52W Low	3.5%	1.8%
Efficiency & Yields
Asset Turnover (TTM)	1.61x	0.58x
FCF Yield (TTM)	0.2%	-14.0%
Earnings Yield (TTM)	-1.3%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	23.0	-57.0
EV/GP/RG	0.25	0.14
Ticker research	View KRMD research	View STXS research